MEN’S HEALTH MONDAY
 
Addressing prostate cancer’s racial disparity starts with you
Several decades of data show that Black men are less likely to be screened and treated for prostate cancer than their white counterparts. In this interview, Kelvin A. Moses, MD, PhD, of Vanderbilt University Medical Center, Nashville, TN discusses the reasons for these disparities and how practicing urologists can address them.
Read the interview
 
New data point to statins’ potential for reducing prostate growth
Results from analyses of data collected in the randomized, placebo-controlled Reduction by Dutasteride of prostate Cancer Events trial point to a potential role for statins in attenuating age-related prostate enlargement.
Learn more
SURVEY
 
Is DRE still a relevant tool in the management of prostate cancer?
 
MORE FROM UROLOGY TIMES
 
How will PARP inhibitors change advanced PCa treatment?
Fusion transcript shows potential for prostate cancer biomarker
JOB OPPORTUNITIES